Sec Form 3 Filing - Maderazo Alan Baer @ GenMark Diagnostics, Inc. - 2020-05-10

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Maderazo Alan Baer 2. Issuer Name and Ticker or Trading Symbol GenMark Diagnostics, Inc. [ GNMK] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) VP, Qual, Reg, & Clin Affaiirs (Last) (First) (Middle) 5964 LA PLACE COURT 3. Date of Earliest Transaction (MM/DD/YY) 05/10/2020 (Street) SAN DIEGO, CA92008 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 268,949 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 11.59 ( 2 ) 11/05/2023 Common Stock 7,500 D Stock Option (Right to Buy) $ 12.3 ( 2 ) 03/06/2024 Common Stock 14,000 D Stock Option (Right to Buy) $ 13.17 ( 2 ) 02/19/2025 Common Stock 37,180 D Market Stock Units $ 0 ( 3 ) ( 3 ) Common Stock 6,250 D Market Stock Units $ 0 ( 4 ) ( 4 ) Common Stock 13,333 D Market Stock Units $ 0 ( 5 ) ( 5 ) Common Stock 25,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Maderazo Alan Baer 5964 LA PLACE COURT SAN DIEGO, CA92008 VP, Qual, Reg, & Clin Affaiirs Signatures /s/ Eric Stier, Attorney-in-fact 05/19/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The amount reported reflects common stock held by the Reporting Person as well as restricted stock units granted to a Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. Of the reported amount, 119,251 shares represent restricted stock units that vest 25% on the first anniversary of the grant date and the remaining shares subject to each award vest in 12 equal quarterly installments thereafter. In addition, 37,500 shares represent restricted stock units that vest 50% on the first anniversary of the grant date and the remaining shares subject to each award vest in 4 equal quarterly installments thereafter. ( 2 )The stock option is fully vested. ( 3 )18,750 MSU's were granted to the Reporting Person on February 27, 2018 and 10,675 shares vested during the years ended December 31, 2018 and December 31, 2019. MSU's vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. ( 4 )20,000 MSU's were granted to the Reporting Person on February 18, 2019 and 4,973 shares vested during the year ended December 31, 2019. MSU's vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. ( 5 )MSU's vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.